Global Myelodysplastic Syndrome Market Research Report 2019

Table of Contents

Executive Summary

1 Myelodysplastic Syndrome Market Overview

• 1.1 Product Overview and Scope of Myelodysplastic Syndrome
• 1.2 Myelodysplastic Syndrome Segment by Type
  • 1.2.1 Global Myelodysplastic Syndrome Production Growth Rate Comparison by Type (2014-2025)
  • 1.2.2 Alkylating Agents
  • 1.2.3 Cytotoxic Antibiotics
  • 1.2.4 Topoisomerase Inhibitors
  • 1.2.5 Others
• 1.3 Myelodysplastic Syndrome Segment by Application
  • 1.3.1 Myelodysplastic Syndrome Consumption Comparison by Application (2014-2025)
  • 1.3.2 Hospital
  • 1.3.3 Clinic
• 1.4 Global Myelodysplastic Syndrome Market by Region
  • 1.4.1 Global Myelodysplastic Syndrome Market Size Region
  • 1.4.2 North America Status and Prospect (2014-2025)
  • 1.4.3 Europe Status and Prospect (2014-2025)
  • 1.4.4 China Status and Prospect (2014-2025)
  • 1.4.5 Japan Status and Prospect (2014-2025)
• 1.5 Global Myelodysplastic Syndrome Market Size
  • 1.5.1 Global Myelodysplastic Syndrome Revenue (2014-2025)
  • 1.5.2 Global Myelodysplastic Syndrome Production (2014-2025)

2 Global Myelodysplastic Syndrome Market Competition by Manufacturers

• 2.1 Global Myelodysplastic Syndrome Production Market Share by Manufacturers (2014-2019)
• 2.2 Global Myelodysplastic Syndrome Revenue Share by Manufacturers (2014-2019)
• 2.3 Global Myelodysplastic Syndrome Average Price by Manufacturers (2014-2019)
• 2.4 Manufacturers Myelodysplastic Syndrome Production Sites, Area Served, Product Types
• 2.5 Myelodysplastic Syndrome Market Competitive Situation and Trends
  • 2.5.1 Myelodysplastic Syndrome Market Concentration Rate
  • 2.5.2 Myelodysplastic Syndrome Market Share of Top 3 and Top 5 Manufacturers
  • 2.5.3 Mergers & Acquisitions, Expansion

3 Global Myelodysplastic Syndrome Production Market Share by Regions

• 3.1 Global Myelodysplastic Syndrome Production Market Share by Regions
• 3.2 Global Myelodysplastic Syndrome Revenue Market Share by Regions (2014-2019)
• 3.3 Global Myelodysplastic Syndrome Production, Revenue, Price and Gross Margin (2014-2019)
• 3.4 North America Myelodysplastic Syndrome Production
  • 3.4.1 North America Myelodysplastic Syndrome Production Growth Rate (2014-2019)
  • 3.4.2 North America Myelodysplastic Syndrome Production, Revenue, Price and Gross Margin (2014-2019)
• 3.5 Europe Myelodysplastic Syndrome Production
  • 3.5.1 Europe Myelodysplastic Syndrome Production Growth Rate (2014-2019)
  • 3.5.2 Europe Myelodysplastic Syndrome Production, Revenue, Price and Gross Margin (2014-2019)
• 3.6 China Myelodysplastic Syndrome Production (2014-2019)
  • 3.6.1 China Myelodysplastic Syndrome Production Growth Rate (2014-2019)
  • 3.6.2 China Myelodysplastic Syndrome Production, Revenue, Price and Gross Margin (2014-2019)
• 3.7 Japan Myelodysplastic Syndrome Production (2014-2019)
  • 3.7.1 Japan Myelodysplastic Syndrome Production Growth Rate (2014-2019)
  • 3.7.2 Japan Myelodysplastic Syndrome Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Myelodysplastic Syndrome Consumption by Regions

• 4.1 Global Myelodysplastic Syndrome Consumption by Regions
• 4.2 North America Myelodysplastic Syndrome Consumption (2014-2019)
• 4.3 Europe Myelodysplastic Syndrome Consumption (2014-2019)
• 4.4 China Myelodysplastic Syndrome Consumption (2014-2019)
• 4.5 Japan Myelodysplastic Syndrome Consumption (2014-2019)

5 Global Myelodysplastic Syndrome Production, Revenue, Price Trend by Type

• 5.1 Global Myelodysplastic Syndrome Production Market Share by Type (2014-2019)
• 5.2 Global Myelodysplastic Syndrome Revenue Market Share by Type (2014-2019)
• 5.3 Global Myelodysplastic Syndrome Price by Type (2014-2019)
• 5.4 Global Myelodysplastic Syndrome Production Growth by Type (2014-2019)

6 Global Myelodysplastic Syndrome Market Analysis by Applications

• 6.1 Global Myelodysplastic Syndrome Consumption Market Share by Application (2014-2019)
• 6.2 Global Myelodysplastic Syndrome Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Myelodysplastic Syndrome Business

• 7.1 Celgene
  • 7.1.1 Celgene Myelodysplastic Syndrome Production Sites and Area Served
  • 7.1.2 Myelodysplastic Syndrome Product Introduction, Application and Specification
  • 7.1.3 Celgene Myelodysplastic Syndrome Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.1.4 Main Business and Markets Served
• 7.2 Novartis
  • 7.2.1 Novartis Myelodysplastic Syndrome Production Sites and Area Served
  • 7.2.2 Myelodysplastic Syndrome Product Introduction, Application and Specification
  • 7.2.3 Novartis Myelodysplastic Syndrome Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.2.4 Main Business and Markets Served
• 7.3 Otsuka
  • 7.3.1 Otsuka Myelodysplastic Syndrome Production Sites and Area Served
  • 7.3.2 Myelodysplastic Syndrome Product Introduction, Application and Specification
  • 7.3.3 Otsuka Myelodysplastic Syndrome Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.3.4 Main Business and Markets Served
• 7.4 Actinium Pharmaceuticals
  • 7.4.1 Actinium Pharmaceuticals Myelodysplastic Syndrome Production Sites and Area Served
  • 7.4.2 Myelodysplastic Syndrome Product Introduction, Application and Specification
  • 7.4.3 Actinium Pharmaceuticals Myelodysplastic Syndrome Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served
• 7.5 Acceleron Pharma
  • 7.5.1 Acceleron Pharma Myelodysplastic Syndrome Production Sites and Area Served
  • 7.5.2 Myelodysplastic Syndrome Product Introduction, Application and Specification
  • 7.5.3 Acceleron Pharma Myelodysplastic Syndrome Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.5.4 Main Business and Markets Served
• 7.6 Bellicum Pharmaceuticals
  • 7.6.1 Bellicum Pharmaceuticals Myelodysplastic Syndrome Production Sites and Area Served
  • 7.6.2 Myelodysplastic Syndrome Product Introduction, Application and Specification
  • 7.6.3 Bellicum Pharmaceuticals Myelodysplastic Syndrome Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.6.4 Main Business and Markets Served
• 7.7 Cornerstone Pharmaceuticals
  • 7.7.1 Cornerstone Pharmaceuticals Myelodysplastic Syndrome Production Sites and Area Served
  • 7.7.2 Myelodysplastic Syndrome Product Introduction, Application and Specification
  • 7.7.3 Cornerstone Pharmaceuticals Myelodysplastic Syndrome Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.7.4 Main Business and Markets Served
• 7.8 CTI BioPharma
  • 7.8.1 CTI BioPharma Myelodysplastic Syndrome Production Sites and Area Served
  • 7.8.2 Myelodysplastic Syndrome Product Introduction, Application and Specification
  • 7.8.3 CTI BioPharma Myelodysplastic Syndrome Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.8.4 Main Business and Markets Served
• 7.9 Onconova Therapeutics
  • 7.9.1 Onconova Therapeutics Myelodysplastic Syndrome Production Sites and Area Served
  • 7.9.2 Myelodysplastic Syndrome Product Introduction, Application and Specification
  • 7.9.3 Onconova Therapeutics Myelodysplastic Syndrome Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.9.4 Main Business and Markets Served
• 7.10 Strategia Therapeutics
  • 7.10.1 Strategia Therapeutics Myelodysplastic Syndrome Production Sites and Area Served
  • 7.10.2 Myelodysplastic Syndrome Product Introduction, Application and Specification
  • 7.10.3 Strategia Therapeutics Myelodysplastic Syndrome Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.10.4 Main Business and Markets Served
• 7.11 KaloBios Pharmaceuticals
• 7.12 Kiadis Pharma
• 7.13 Mirati Therapeutics
• 7.14 Astex
• 7.15 Celator Pharmaceuticals
• 7.16 Eli-lilly
• 7.17 Sunesis Pharmaceuticals
• 7.18 Targazyme
• 7.19 Gamida Cell
• 7.20 GlaxoSmithKline
• 7.21 Sumitomo Dainippon Pharma
• 7.22 TetraLogic Pharmaceuticals

8 Myelodysplastic Syndrome Manufacturing Cost Analysis

• 8.1 Myelodysplastic Syndrome Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Myelodysplastic Syndrome
• 8.4 Myelodysplastic Syndrome Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
• 9.2 Myelodysplastic Syndrome Distributors List
• 9.3 Myelodysplastic Syndrome Customers

10 Market Dynamics

• 10.1 Market Trends
• 10.2 Opportunities
• 10.3 Market Drivers
• 10.4 Challenges
• 10.5 Influence Factors

11 Global Myelodysplastic Syndrome Market Forecast

• 11.1 Global Myelodysplastic Syndrome Production, Revenue Forecast
  • 11.1.1 Global Myelodysplastic Syndrome Production Growth Rate Forecast (2019-2025)
  • 11.1.2 Global Myelodysplastic Syndrome Revenue and Growth Rate Forecast (2019-2025)
  • 11.1.3 Global Myelodysplastic Syndrome Price and Trend Forecast (2019-2025)
• 11.2 Global Myelodysplastic Syndrome Production Forecast by Regions (2019-2025)
  • 11.2.1 North America Myelodysplastic Syndrome Production, Revenue Forecast (2019-2025)
  • 11.2.2 Europe Myelodysplastic Syndrome Production, Revenue Forecast (2019-2025)
  • 11.2.3 China Myelodysplastic Syndrome Production, Revenue Forecast (2019-2025)
  • 11.2.4 Japan Myelodysplastic Syndrome Production, Revenue Forecast (2019-2025)
• 11.3 Global Myelodysplastic Syndrome Consumption Forecast by Regions (2019-2025)
  • 11.3.1 North America Myelodysplastic Syndrome Consumption Forecast (2019-2025)
  • 11.3.2 Europe Myelodysplastic Syndrome Consumption Forecast (2019-2025)
  • 11.3.3 China Myelodysplastic Syndrome Consumption Forecast (2019-2025)
  • 11.3.4 Japan Myelodysplastic Syndrome Consumption Forecast (2019-2025)
• 11.4 Global Myelodysplastic Syndrome Production, Revenue and Price Forecast by Type (2019-2025)
• 11.5 Global Myelodysplastic Syndrome Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List